- Immunotherapy is a cutting-edge approach that leverages the body’s own immune system to combat cancer. This innovative treatment method encompasses a range of therapies, including checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines. By engaging the immune system, immunotherapy works to identify and destroy cancer cells, offering a promising alternative to traditional treatments.
- Checkpoint inhibitors, for instance, target specific molecules that hinder the immune system’s natural response to cancer, allowing immune cells to recognize and attack the cancer. CAR-T cell therapy involves the modification of a patient’s own immune cells to specifically target cancer cells. Cancer vaccines, on the other hand, stimulate the immune system to recognize and fight cancer more effectively. Immunotherapy has shown remarkable success in various cancer types, offering new hope to many patients.
- Hormone therapy, on the other hand, is primarily utilized in the management of hormone-sensitive cancers, such as breast and prostate cancer. This therapy works by either blocking the production of hormones that fuel cancer growth or by altering their effects. By interfering with these hormonal pathways, hormone therapy aims to slow down or halt cancer progression, often as a crucial component of the overall treatment plan.
- The choice of treatment, whether immunotherapy or hormone therapy, depends on the specific type of cancer, its characteristics, and individual patient factors. Both approaches represent significant advancements in the field of oncology, broadening the array of options available to patients and enhancing the prospects for successful cancer management.
Immunotherapy
